Eurobio Scientific Société anonyme (EPA:ALERS)
France · Delayed Price · Currency is EUR 20.00
-0.40 (-1.96%)
Aug 21, 2026, 5:13 PM CET
EPA:ALERS Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 168.6 | 168.6 | 154.56 | 130.65 | 152.9 | 185.32 |
Revenue Growth | 3.77% | 9.08% | 18.30% | -14.56% | -17.50% | -2.04% |
Gross Profit Gross Profit Growth | 76.85 | 76.85 | 71.57 | 57.49 | 71.24 | 99.41 |
Operating Income Operating Income Growth | 10.74 | 10.74 | 13.33 | 10.14 | 30.87 | 70.12 |
Net Income Net Income Growth | 4.87 | 4.87 | 4 | 4.84 | 24.94 | 60.54 |
Earnings Per Share EPS Growth | 0.47 | 0.47 | 0.39 | 0.43 | 2.20 | 5.57 |
EPS Growth | 109.44% | 20.51% | -9.30% | -80.44% | -60.53% | -14.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
France France Growth | 97.82 | 97.82 | 90.84 | 82.73 | 127.57 | 166.83 |
Europe (Excluding France) Europe (Excluding France) Growth | 58.22 | 58.22 | 53.56 | 38.79 | 21.8 | 16.81 |
United States and Australia United States and Australia Growth | 12.67 | 12.67 | 10.21 | - | - | - |
Total Total Growth | 168.71 | 168.71 | 154.61 | 130.65 | 152.9 | 185.32 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 20.66 | 20.66 | 23.07 | 89.03 | 85.94 | 102.39 |
Total Debt Total Debt Growth | 16 | 16 | 9.77 | 100.66 | 113.64 | 15.69 |
Net Cash (Debt) Net Cash Growth | 4.66 | 4.66 | 13.3 | -11.63 | -27.7 | 86.7 |
Net Cash Growth | -53.90% | -64.95% | - | - | - | 141.89% |
Net Cash Per Share Net Cash Per Share Growth | 0.45 | 0.45 | 1.30 | -1.04 | -2.44 | 7.97 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18.85 | 18.85 | 16.7 | 26.77 | 43.07 | 65.92 |
Capital Expenditures CapEx Growth | -12.57 | -12.57 | -3.26 | -4.05 | -2.83 | -1.85 |
Free Cash Flow Free Cash Flow Growth | 6.28 | 6.28 | 13.45 | 22.71 | 40.24 | 64.07 |
Free Cash Flow Growth | -44.49% | -53.28% | -40.80% | -43.55% | -37.19% | 21.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.58% | 45.58% | 46.30% | 44.00% | 46.59% | 53.64% |
Operating Margin | 6.37% | 6.37% | 8.63% | 7.76% | 20.19% | 37.84% |
Pretax Margin | 4.63% | 4.63% | 4.07% | 5.34% | 19.41% | 38.48% |
Profit Margin | 2.89% | 2.89% | 2.59% | 3.70% | 16.31% | 32.67% |
FCF Margin | 3.73% | 3.73% | 8.70% | 17.39% | 26.32% | 34.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.34 | 50.39 | 63.43 | 34.81 | 8.86 | 4.83 |
Forward PE | 17.61 | 25.50 | 25.38 | 17.33 | 10.63 | 7.73 |
P/FCF Ratio | 31.89 | 39.02 | 18.86 | 7.41 | 5.49 | 4.56 |
PS Ratio | 1.19 | 1.45 | 1.64 | 1.29 | 1.44 | 1.58 |